Growth Equity Opportunities 17 LLC 13D and 13G filings for VistaGen Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-12 5:15 pm Sale | 2022-07-22 | 13D | VistaGen Therapeutics, Inc. VTGN | Growth Equity Opportunities 17 LLC | 0 0.000% | -543,420 (Position Closed) | Filing |
| 2021-04-29 10:17 am Purchase | 2021-03-26 | 13D | VistaGen Therapeutics, Inc. VTGN | Growth Equity Opportunities 17 LLC | 543,420 8.600% | 231,420 (+74.17%) | Filing |
| 2021-01-04 06:00 am Purchase | 2020-12-22 | 13D | VistaGen Therapeutics, Inc. VTGN | Growth Equity Opportunities 17 LLC | 312,000 6.800% | 312,000 (New Position) | Filing |